pentobarbital will lower the level or result of elbasvir/grazoprevir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic result of elbasvir/grazoprevir might be diminished if coadministered with strong CYP3A inducers which is therefore contraindicated.pentobarbital will lessen the extent or influence of olicer